Human Glycoprotein IIb/IIIa Receptor Monoclonal Antibody

Produktübersicht

• Artikelname: Human Glycoprotein IIb/IIIa Receptor Monoclonal Antibody
• Artikelnummer: ABB-YR0105
• Hersteller Artikelnummer: YR0105
• Alternativnummer: ABB-YR0105-5MG,ABB-YR0105-1MG,ABB-YR0105-20MG
• Hersteller: ABclonal
• Kategorie: Antikörper
• Applikation: ELISA, NeA
• Immunogen: glycoprotein (GP) IIb/IIIa

Produktbeschreibung

Abciximab Biosimilar uses the same protein sequences as the therapeutic antibody abciximab.Abciximab, a glycoprotein IIb/IIIa receptor antagonist, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.While abciximab has a short plasma half-life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 96 to 120 hours after discontinuation of the drug. Abciximab is made from the Fab fragments of an immunoglobulin that targets the glycoprotein IIb/IIIa receptor on the platelet membrane.

Produkteigenschaften

• Reinheit: >95% Determined by SDS-PAGE
• Target-Kategorie: Glycoprotein IIb/IIIa

Anwendungsbeschreibung

• Application Verdünnung: In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
• Anwendungsbeschreibung: Cross-Reactivity: <1EU/mg (<0.001EU/µg)Determined by LAL gel clotting assay. ResearchArea: Cancer immunology